{"id":54402,"date":"2023-03-01T22:03:10","date_gmt":"2023-03-01T21:03:10","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/"},"modified":"2023-03-01T22:03:10","modified_gmt":"2023-03-01T21:03:10","slug":"urogen-pharma-to-present-at-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/","title":{"rendered":"UroGen Pharma to Present at Upcoming Investor Conferences"},"content":{"rendered":"<div>\n<p>PRINCETON, N.J.&#8211;(BUSINESS WIRE)&#8211;UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will present at the following investor conferences in March:\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230301005965\/en\/1727455\/5\/UroGen_logo2_%28R%29.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230301005965\/en\/1727455\/21\/UroGen_logo2_%28R%29.jpg\"><\/a><\/p>\n<p>\nCowen 43<sup>rd<\/sup> Annual Health Care Conference \u2014 March 7-9, 2023\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nPanel Presentation Date: Tuesday, March 7<sup>th<\/sup> from 12:50-1:50pm ET\n<\/li>\n<li>\nWebcast Link: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwst-dot-yamm-track.appspot.com%2F2Cp1ZjAsXmTAF7xVoVAbya2ssU_jzobVMZ5TQqmCJChbV85FLhgGxAxtUIY2dVEA_dBCp6WaC5Q9J14tL8Jkp05BIy3i9FnkScqbgekHipm7K8CEGCvffHcdpNWCINQlVa3YzfaaeafIfJQAwQ6S58-L_Kl1D1f-4fl74XXMEF0WBgeKuD5B6ZRK6snhYwnYGr7HlYemfl5yad0UP&amp;esheet=53354570&amp;newsitemid=20230301005965&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwsw.com%2Fwebcast%2Fcowen132%2Fpanel12%2F2317014&amp;index=1&amp;md5=c72d37e6aa7a51d47d4e965a1cf841ea\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/wsw.com\/webcast\/cowen132\/panel12\/2317014<\/a>\n<\/li>\n<\/ul>\n<p>\nOppenheimer 33<sup>rd<\/sup> Annual Healthcare Conference \u2014 March 13-15, 2023\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nPresentation Date: Tuesday, March 14<sup>th<\/sup> from 10:40-11:10am ET\n<\/li>\n<li>\nWebcast Link: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwsw.com%2Fwebcast%2Foppenheimer27%2Furgn%2F2810892&amp;esheet=53354570&amp;newsitemid=20230301005965&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwsw.com%2Fwebcast%2Foppenheimer27%2Furgn%2F2810892&amp;index=2&amp;md5=ec2b1240fcf482b4b7baf5247128b3e6\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/wsw.com\/webcast\/oppenheimer27\/urgn\/2810892<\/a>\n<\/li>\n<\/ul>\n<p>\nWebcasts for both the Cowen and Oppenheimer presentations will be available via the Investors section of UroGen\u2019s website, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.urogen.com&amp;esheet=53354570&amp;newsitemid=20230301005965&amp;lan=en-US&amp;anchor=www.urogen.com&amp;index=3&amp;md5=1b9198e024d50712a86baa12553ff8f3\" rel=\"nofollow noopener\" shape=\"rect\">www.urogen.com<\/a>. A replay of each webcast will be available on the Company\u2019s website for approximately 30 days.\n<\/p>\n<p>\n<b>About UroGen Pharma Ltd.<\/b>\n<\/p>\n<p>\nUroGen is biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers because patients deserve better options. UroGen has developed RTGel\u2122 reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. UroGen\u2019s sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. UroGen\u2019s first commercial product JELMYTO (mitomycin) for pyelocalyceal solution, and investigational treatment UGN-102 (mitomycin) for intravesical solution for patients with low-grade non-muscle invasive bladder cancer, are designed to ablate tumors by non-surgical means. UroGen is headquartered in Princeton, NJ with operations in Israel. Visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.urogen.com&amp;esheet=53354570&amp;newsitemid=20230301005965&amp;lan=en-US&amp;anchor=www.urogen.com&amp;index=4&amp;md5=27ac6cd5f77b191a61c4ac18ec59ac87\" rel=\"nofollow noopener\" shape=\"rect\">www.urogen.com<\/a> to learn more or follow us on Twitter, @UroGenPharma.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>INVESTOR CONTACT:<\/b><br \/>Vincent Perrone<br \/>\n<br \/>Senior Director, Investor Relations<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#x6c;t&#x6f;&#58;v&#x69;&#110;c&#x65;&#110;&#x74;&#x2e;p&#x65;&#114;r&#x6f;&#110;e&#x40;&#117;&#x72;&#x6f;&#103;&#x65;&#x6e;&#46;&#x63;&#111;m\" rel=\"nofollow noopener\" shape=\"rect\">&#118;&#x69;&#110;&#x63;e&#x6e;t&#46;&#x70;&#101;&#x72;r&#x6f;n&#101;&#x40;&#117;&#x72;o&#x67;e&#110;&#x2e;&#99;&#x6f;m<\/a><br \/>609-460-3588 ext. 1093\n<\/p>\n<p>\n<b>MEDIA CONTACT:<\/b><br \/>Cindy Romano<br \/>\n<br \/>UroGen Corporate Communications<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;:&#x63;i&#x6e;d&#121;&#x2e;&#114;&#x6f;&#109;&#x61;&#110;&#x6f;&#64;&#x75;r&#x6f;g&#101;&#x6e;&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">ci&#110;&#100;&#121;&#x2e;&#x72;&#x6f;&#x6d;an&#111;&#64;&#117;&#x72;&#x6f;&#x67;&#x65;n&#46;&#99;&#111;&#109;<\/a><br \/>908-963-7827\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>PRINCETON, N.J.&#8211;(BUSINESS WIRE)&#8211;UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will present at the following investor conferences in March: Cowen 43rd Annual Health Care Conference \u2014 March 7-9, 2023 Panel Presentation Date: Tuesday, March 7th from 12:50-1:50pm ET &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54402","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>UroGen Pharma to Present at Upcoming Investor Conferences - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UroGen Pharma to Present at Upcoming Investor Conferences - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PRINCETON, N.J.&#8211;(BUSINESS WIRE)&#8211;UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will present at the following investor conferences in March: Cowen 43rd Annual Health Care Conference \u2014 March 7-9, 2023 Panel Presentation Date: Tuesday, March 7th from 12:50-1:50pm ET ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-01T21:03:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230301005965\/en\/1727455\/21\/UroGen_logo2_%28R%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"UroGen Pharma to Present at Upcoming Investor Conferences\",\"datePublished\":\"2023-03-01T21:03:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-upcoming-investor-conferences\\\/\"},\"wordCount\":299,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230301005965\\\/en\\\/1727455\\\/21\\\/UroGen_logo2_%28R%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-upcoming-investor-conferences\\\/\",\"name\":\"UroGen Pharma to Present at Upcoming Investor Conferences - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230301005965\\\/en\\\/1727455\\\/21\\\/UroGen_logo2_%28R%29.jpg\",\"datePublished\":\"2023-03-01T21:03:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230301005965\\\/en\\\/1727455\\\/21\\\/UroGen_logo2_%28R%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230301005965\\\/en\\\/1727455\\\/21\\\/UroGen_logo2_%28R%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UroGen Pharma to Present at Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UroGen Pharma to Present at Upcoming Investor Conferences - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"UroGen Pharma to Present at Upcoming Investor Conferences - Pharma Trend","og_description":"PRINCETON, N.J.&#8211;(BUSINESS WIRE)&#8211;UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will present at the following investor conferences in March: Cowen 43rd Annual Health Care Conference \u2014 March 7-9, 2023 Panel Presentation Date: Tuesday, March 7th from 12:50-1:50pm ET ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-01T21:03:10+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230301005965\/en\/1727455\/21\/UroGen_logo2_%28R%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"UroGen Pharma to Present at Upcoming Investor Conferences","datePublished":"2023-03-01T21:03:10+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/"},"wordCount":299,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230301005965\/en\/1727455\/21\/UroGen_logo2_%28R%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/","url":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/","name":"UroGen Pharma to Present at Upcoming Investor Conferences - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230301005965\/en\/1727455\/21\/UroGen_logo2_%28R%29.jpg","datePublished":"2023-03-01T21:03:10+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230301005965\/en\/1727455\/21\/UroGen_logo2_%28R%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230301005965\/en\/1727455\/21\/UroGen_logo2_%28R%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"UroGen Pharma to Present at Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54402","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54402"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54402\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54402"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54402"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54402"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}